Get 20% lifetime commission for referring investors to digrin.com
here.
Enanta Pharmaceuticals, Inc. ( ENTA) - Stock Earnings
ENTA Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -11.9 million USD | 18.6 million USD |
| 2026Q1 | -13.1 million USD | 17.2 million USD |
| 2026Q2 | -19.5 million USD | 14.4 million USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
ENTA Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -133.8 million USD | 79.2 million USD |
| 2024 | -116.0 million USD | 67.6 million USD |
| 2025 | -81.9 million USD | 65.3 million USD |
| 2026 Est. | — | — |
ENTA
Price: $12.83
52 week price:
Earnings Per Share: -2.42 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 3045
Ebitda: 15.9 millionMarket Capitalization: 383.3 million